[Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. / Chronisch-entzündliche Darmerkrankungen in der COVID-Pandemie: Manifestationen und Management.
Z Gastroenterol
; 60(12): 1795-1801, 2022 Dec.
Article
en De
| MEDLINE
| ID: mdl-35148564
ABSTRACT
The COVID-19 pandemic is significantly affecting the lives of patients with inflammatory bowel disease (IBD). Those affected and their relatives have numerous questions about the risk of the disease, the course of a possible SARS-CoV-2 infection or the influence of CED-specific therapy on these. Many IBD patients also have additional questions about the safety and effectiveness of a vaccination against SARS-CoV-2. The aim of this review is to summarize the latest findings on COVID-19 and IBD, but also to discuss vaccine response (humoral/cellular), the influence of ongoing therapy on the vaccine response as well as the frequency of side effects and the importance of booster immunizations and to create an evidence-based basis for discussion with patients.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Enfermedades Inflamatorias del Intestino
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
COVID-19
Límite:
Humans
Idioma:
De
Revista:
Z Gastroenterol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania